Main Article Content
telogen effluvium, hair loss, COVID-19
Objective: The purpose of this study was to assess the public interest in the United States of telogen effluvium before and after the COVID-19 pandemic in order to investigate the best therapeutic interventions for dermatologists in the future.
Methods: We performed Google TrendsTM search for “COVID hair loss”, “telogen effluvium” and “hair loss” between 5/1/20 and 8/16/20.
Conclusion: All three terms have increased in popularity for search terms since mid-March and were the most prevalent in the states that experienced the earliest increase in number of coronavirus cases.
2. Rivetti, N. and Barruscotti, S. Management of telogen effluvium during the COVID‐19 emergency: Psychological implications. Dermatol Ther. 2020 May 22;e13923. doi:10.1111/dth.13648
3. Effenberger, M., Kronbichler, A., Shin, J. et al. Association of the COVID-19 pandemic with Internet Search Volumes: A Google TrendsTM Analysis. Int J Infect Dis. 2020 Apr 17; 202095, 192–197. https://doi.org/10.1016/j.ijid.2020.04.033
4. Oster, Alexandra M, et al. “Trends in Number and Distribution of COVID-19 Hotspot Counties - United States, March 8–July 15, 2020.” Centers for Disease Control and Prevention, Centers for Disease Control and Prevention, 20 Aug. 2020, www.cdc.gov/mmwr/volumes/69/wr/mm6933e2.htm.
5. CDC COVID Data Tracker. (n.d.). Retrieved January 12, 2021, from https://covid.cdc.gov/covid-data-tracker/#trends_dailytrendscases
6. Cline, A, Kazemi, A, Moy, J, et al. Surge in the Incidence of Telogen Effluvium in Minority Predominant Communities Heavily Impacted by COVID-19. J Am Acad Dermatol. 2020 Oct 5.